Clinical Trial of Rifampin and Azithromycin for the Treatment of River Blindness

NCT00127504 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

80

Enrollment

FED

Sponsor class

Conditions

Onchocerciasis

Interventions

DRUG: Rifampin
DRUG: Azithromycin

Sponsor

Centers for Disease Control and Prevention

Collaborators

[object Object]
[object Object]